- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01130558
Efficacy of Structured Insulin Order
May 24, 2010 updated by: Massachusetts General Hospital
Efficacy of Structured Insulin Orders in Improving Glycemic Control
The purpose of this study is to determine whether an electronic order template for basal-bolus insulin will improve mean blood glucose in hospitalized general medical patients with poorly controlled type 2 diabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study randomly assigned internal medicine residents to use an electronic insulin order template plus basal-bolus ordering education versus education only.
For all patients with uncontrolled type 2 diabetes treated by these physicians, mean blood glucose, rate of hypoglycemia, and rate of sliding scale insulin use were measured.
Study Type
Interventional
Enrollment (Actual)
128
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Blood glucose less than 60 mg/dl or greater than 180 mg/dl during hospital stay
Exclusion Criteria:
- Diagnosis of Type 1 Diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Ordering template and education
Internal medical residents who were asked to use the insulin order template and received education about basal-bolus insulin ordering.
|
Using electronic insulin order template for basal-bolus insulin and education
|
Active Comparator: Education
Internal medical residents who received education about basal-bolus insulin ordering.
|
Using electronic insulin order template for basal-bolus insulin and education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean blood Glucose
Time Frame: 6 days
|
6 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
rates of glucose values less than 60 mg/dl or less than 40 mg/dl
Time Frame: 6 days
|
6 days
|
rate of use of sliding scale insulin
Time Frame: 6 days
|
6 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Enrico Cagliero, M.D., Massachusetts General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
June 1, 2009
Study Registration Dates
First Submitted
May 24, 2010
First Submitted That Met QC Criteria
May 24, 2010
First Posted (Estimate)
May 26, 2010
Study Record Updates
Last Update Posted (Estimate)
May 26, 2010
Last Update Submitted That Met QC Criteria
May 24, 2010
Last Verified
May 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008P-0022131
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
Clinical Trials on Diabetes Management
-
OsakidetzaFondo de Investigacion Sanitaria; Kronikgune-- Association Centre of International... and other collaboratorsCompleted
-
Chungbuk National UniversityCompleted
-
University of MichiganRecruiting
-
University of MichiganNational Institutes of Health (NIH); National Institute on Aging (NIA); Blue...Completed
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2United States
-
University of ArkansasPatient-Centered Outcomes Research InstituteActive, not recruitingDiabetes Mellitus, Type 2United States
-
Boston CollegeNational Institute of Nursing Research (NINR); National Institutes of Health...Not yet recruitingDiabetes Mellitus, Type 2 | Patient Engagement | Patient EducationUnited States
-
University of NottinghamCompletedDiabetes Mellitus, Type 2 | Health BehaviorJordan
-
InSpark Technologies, Inc.University of VirginiaCompleted
-
Texas AgriLife Extension ServiceTexas A&M UniversityCompletedType 2 Diabetes, Hispanic/Latinos, Diabetes Self-management Education